Search Orphan Drug Designations and Approvals
-
| Generic Name: | adeno-associated virus (AAV) gene therapy product that comprised a modified AAV2 capsid and a light sensitive transgene |
|---|---|
| Date Designated: | 08/20/2024 |
| Orphan Designation: | treatment of retinitis pigmentosa |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Skyline Therapeutics (US) Inc. 1 Main Street, 13th Floor, Cambridge, MA Cambridge, Massachusetts 02129 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







